Mebihusk 135 Tablet contains Mebeverine 135 mg, a muscle relaxant and antispasmodic used to relieve abdominal pain, cramps, and discomfort associated with irritable bowel syndrome (IBS) and other gastrointestinal spasms.
Mebeverine works by relaxing the smooth muscles of the gastrointestinal tract, reducing spastic contractions without affecting normal bowel function. This provides effective symptomatic relief for patients experiencing chronic digestive discomfort.
Belonging to the gastroenterology segment, Mebihusk 135 Tablet is widely prescribed by gastroenterologists and general physicians. Its consistent efficacy and patient adherence make it a high-demand product in hospitals, clinics, and retail pharmacies.
For PCD pharma franchise partners, third-party manufacturers, and exporters, Mebihusk 135 Tablet offers a profitable B2B opportunity. Its inclusion in standard gastrointestinal care ensures recurring demand and a stable market presence across India.
Common side effects may include throat irritation, cough, headache, dry mouth, or mild tremors. Rarely, patients may experience palpitations, allergic reactions, or increased heart rate. Seek immediate medical attention if severe difficulty breathing, chest pain, or swelling occurs.
Tropiturn Trio Rota Capsule is indicated for the management of moderate to severe asthma and chronic obstructive pulmonary disease (COPD). It helps reduce wheezing, shortness of breath, and improves overall lung function in patients with persistent respiratory symptoms.
Use Tropiturn Trio Rota Capsule exactly as prescribed, usually via a rotacapsule inhalation device. Do not exceed the recommended dose. Rinse your mouth after inhalation to prevent oral infections. Inform your doctor if you have heart disease, glaucoma, urinary retention, or thyroid disorders.
Store Tropiturn Trio Rota Capsule in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep out of reach of children.